posted
Play this carefully. Management is very shrewd and inexperienced. They will be slowly diluting and increasing their O/S. I talked to Scott before the R/S and they are short of money. There are other good plays at these levels. Rather put money in CEAT.
-------------------- Almost There....
IP: Logged |
posted
Ingen is getting ready to make the move to the BB very soon. I would expect it to jump the first day it moves over. Picked up another 10,000 shares hoping for the best. With the pr that came out today I think Ingen will do very well in the medical device industry.
This is only my thinking and my opinion, may not happen so don't go by my word.
-------------------- The thing I learned most about this is to take a profit when you can and you gotta have PATIENCE!
IP: Logged |
posted
Ingen Technologies, Inc. Secure Balance(TM) Reaches the Consumer Markets PR Newswire - February 09, 2006 07:15 - Secure Balance(TM) at AAN With 8,000 Neurologists -
CALIMESA, Calif., Feb 09, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (OTC: IGTG), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that the company's Secure Balance(TM) products will be televised on major news stations to millions of consumers throughout the United States and abroad.
The Secure Balance(TM) products are gaining increasing public awareness through direct advertising, workshops and trade shows. Max World News TV is filming this weekend in Jacksonville-Florida where the company has a major Secure Balance(TM) workshop. The filming will be used to develop a major news story about the benefits of Secure Balance(TM) and how it provides a healthier lifestyle for people, and at the same time saves millions of dollars with our Federal Health & Welfare budget.
The company is also scheduled to exhibit Secure Balance(TM) in San Diego at the 2006 - Annual Meeting of the American Academy of Neurology (AAN). The American Academy of Neurology (AAN) provides valuable resources for medical specialists worldwide who are committed to improving the care of patients with neurological diseases. The AAN's nearly 19,000 members look to the AAN for the most comprehensive professional development, career enhancement, and practice improvement opportunities available. More than 8,000 neurologists are expected to attend this four day event.
"The Secure Balance(TM) products have made solid inroads among neurologists, chiropractors and physical therapists. There is a $400M neurology market, and the $500M Chiropractic market. We have a strong attendance at our next clinical workshop, and we average about 15 new leads per week," said Scott Sand, Chairman & CEO.
About Ingen Technologies, Inc.
Ingen Technologies, Inc. is a public company trading under NASDAQ OTC:IGTG, which has been in business since 1999. IGTG is a medical device manufacturer and a growth-oriented company that owns US patent(s), trademarks, and proprietary medical products.
The Company's flagship product is OxyAlert(TM), a second-generation design of the Company's BAFI(TM) product line. Both of these products have been issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No. 6,326,896 issued on December 4, 2001. Both of these products are low-oxygen safety warning devices used on remote oxygen cylinders for patients, commercial aircraft, military transport, and fire and safety equipment. OxyAlert(TM) technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance.
The newest product, OxyView(TM), has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow for patients in the hospital, surgical room, outpatient therapy, nursing homes and emergency response facilities. This product enhances the safety, assurance and accuracy of patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of the oxygen flow rate near the patient. It could quickly inform the physician or technician of any leak or inaccuracy between the delivery source and the patient.
The Secure Balance(TM) product is a private-label product that includes a vestibular function testing system and balance therapy system. The vestibular function testing system is manufactured by Interacoustics LTD. in Denmark and is referred to as the VNG. The balance therapy system is manufactured by SportKAT(R), Inc. in San Diego, California. The Secure Balance(TM) program provides equipment, education and training about balance and fall prevention to physicians and clinicians worldwide.
The Pure Produce(TM) product is a continuing research & development program currently under design. This program uses hydroponics technology to grow various plants without the use of soil, fertilizer and water consumption. The Company anticipates entering the nutriceutical and pharmaceutical markets over the next two years.
"Our team of professionals has developed our medical products for the ever-increasing elderly population. Our products are superior to any of our competition and they allow for effective medical product availability to seniors, and at the same time the increasing senior population allows for a steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen Technologies.
Investor Relations Contact: Scott R. Sand, C.E.O. & Chairman Ingen Technologies, Inc. - Administrative Office 35193 Avenue "A", Suite-C Yucaipa, California 92399 Phone: (800) 259-9622 or (909) 790-7180 Fax: (800) 777-1186 or (909) 795-6340 Email: Info*ingen-tech.com A Member of the Better Business Bureau A Member of the Chamber of Commerce A Licensed Business in the City of Yucaipa
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements that are made pursuant to "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.
SOURCE Ingen Technologies, Inc.
Scott R. Sand, C.E.O. & Chairman of Ingen Technologies, Inc., +1-800-259-9622, or +1-909-790-7180, or fax, +1-800-777-1186, or fax +1-909-795-6340, Info*ingen-tech.com
posted
I'd post this on the .10 board but it's gone? This penny stock is growing and looks like we're setting up for another run this week. Historically, a number of PRs run in series and pump it up.
Ingen Technologies, Inc. IGTG Finalizes Marketing Agreement With Secure Health, Inc. 07:20 a.m. 02/22/2006 Provided by
- Secure Health Will Target the $500M Chiropractic Market - CALIMESA, Calif., Feb 22, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (IGTG), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that the company's Secure Balance(TM) products will be marketed by Secure Health, Inc., and Secure Health expects to create $21M in new revenues for Ingen Technologies over the next 12 months.
"I had a tremendous meeting yesterday with Dr. Michael Koch. He is on-board with our program. He has a tremendous amount of passion and knowledge for balance medicine and treatment. We are forging ahead with our seminar program, publishing articles, 'guest speaker' appearances and much more in the chiropractic industry," said Daniel Scherer, President of Secure Health. Daniel Scherer, President of Secure Health, Inc., specializes in market development, and has more than 10 years of successful experience in developing markets in the chiropractic industry. With more than 60,000 licensed chiropractors in the United States, Mr. Scherer comes to Ingen Technologies to expand Secure Balance sales in the multi-billion dollar chiropractic market. Michael Koch, DC is a leading chiropractor specializing in balance testing and therapy as a means of both preventing fall injuries and treating patients with balance problems in a chiropractic setting.
During the last several months, the Company has created "Secure Balance(TM)" as a brand name in the chiropractic market through precisive advertising in professional trade journals, such as DynamicChiropractic(R), Chiropractic Economics(R), American Chiropractor(R) and various other product journals. Reaching nearly 50% of the chiropractic market, and engaging Secure Health to spearhead the increase in sales, the Company anticipates having a very positive influence within this industry.
"Mr. Scherer and I have been negotiating for several months. A 5-year contract was signed this month and we plan to offer the Secure Balance(TM) products, and in addition, a complete marketing package through MediaMix, Inc. to the vast majority of the chiropractic market," said Scott Sand, Chairman & CEO.
Currently the company has been developing chiropractic leads through the advertising trade journals. The Secure Balance(TM) product, specifically the Secure Balance Therapy Trainer(R), will provide balance therapy and rehab for chiropractic patients with balance problems. The Secure Balance Therapy Trainer(R) sells for $17,900, and that price includes the training and installation, and this procedure is recognized by Medicare, MediCaid and all of the various insurances as a reimbursable item. Secure Health has the ability and resources to reach 2% of the chiropractic market over the next 12 months. This could represent company revenues of more than $21M.
-------------------- Trust but verify!
IP: Logged |
posted
If you look back at some of the pr's IGTG put out they said, which would be sometime in March that they will be moving over to the BB. Hopefully this is still on schedule and will happen. I still expect this to go past the $1 mark after the move. Cha Ching and I can relax for the rest of the year. Thanks INGEN!!! I hope I am not wishfull thinking! Just my opinion on what could happen.
IP: Logged |
quote:Originally posted by abefroman: up 40% on little volume - anyone know what's up?
Typically they like to string together a couple of PRs. I am expecting significant news over the next week. IMO if this stock can maintain the pps here or above and more news regarding the audit and move is announced, then I think we will see it move and move big.
For some this may be old news but it's worth repeating. Note that the timeframe committed to for completing the audits is next week:
Knobias 09:47 a.m. 01/27/2006
Ridgeland, MS, JAN 27, 2006 (EventX/Knobias.com via COMTEX) -- Ingen Technologies, Inc. (IGTG) announced that the company auditors, Spector & Wong, LLP, have committed to complete the remaining audits and accounting within the next 5 weeks. Ingen technologies have been provided the final auditing schedule to complete the required SEC filings in order to take IGTG to the OTCBB. Harold Spector, President of Spector & Wong, LLP has committed to a 5 week schedule to complete all of the 10-KSB(s) and 10-QSB(s) between June 30, 1998 and February 28, 2002. The other audited statements after February 28, 2002 have either been filed or are complete and being processed by the law firm of Peter Wilke.
"I want to make it very clear that attorney Richard Weed has been instructed to start the process to move IGTG to the Bulletin Board and off the Pink-Sheets. The auditors have already completed the most difficult audits and accounting, and they can now simply complete the paperwork required to audit the years prior to the merger that were delinquent. This should be complete in early March-2006," said Scott Sand, Chairman & CEO.
Chris Wirth, Director stated: "With a 300% increase in revenues and profits, moving to the OTCBB will provide great advantages to everyone, including the shareholders and investors who are watching this stock. The continued synergies between IGTG and its growth patterns define a successful future for this company and its many shareholders."
Mr. Sand, CEO & Chairman, has agreed to retire 50% of his personal debt owed to him by the company, as well as develop a share buy-back program in the near future. The company is evaluating various methods to retain share value and minimize any dilution.
-------------------- Trust but verify!
IP: Logged |
posted
Ingen Technologies, Inc. Announces Aggressive Buy Recommendation From Chartered Financial Analyst 07:15 a.m. 03/01/2006 Provided by
- Chartered Financial Analyst Report of IGTG - CALIMESA, Calif., March 1, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (IGTG), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance (TM), announced today that its common stock has been recommended as an "Aggressive Buy" by Empire Research Associates, Inc. ("Empire Research"). Empire Research is a NJ-based consulting firm that specializes in investment research, financial consulting and economic analysis. Mr. William Walling, a Chartered Financial Analyst, has over 35 years experience in developing analyst reports for large and small companies.
Commenting on this development, Scott Sand, CEO of Ingen Technologies, said: "We are very pleased to receive this recommendation as an Aggressive Buy from Empire Research. Its research group has over 100 years of top-drawer experience in evaluating securities, and is led by Bill Walling, a Chartered Financial Analyst, who is also a former four-time member of the Institutional Investor Magazine All-America Research Team. When we engaged Empire Research to write a research report about Ingen, we specified that we wanted an objective analysis, for the intended benefit of our shareholders, other investors, and management. We believe Empire Research has met this standard by identifying and discussing Ingen's corporate challenges and opportunities. We are, of course, gratified that it has reached the positive investment conclusion that both our outlook and common shares are attractive. In particular, I want to bring to your attention a couple of key statements about Ingen's outlook from Empire Research's 21-page Basic Report on our Company. These are: '... We believe that Ingen's burgeoning product line will: (1) serve a large and growing population of the elderly, domestically and internationally, and (2) provide innovative and competitively attractive features, which should permit rapid market penetration. The outcome should be initially, rapid growth in revenues, followed by rising earnings...' and 'Basically, we expect Ingen's product quality and marketing prowess to boost revenues, earnings, and its share price, despite the prospect of more shares being issued to finance growth. More specifically, we expect Ingen to raise sales to a $10 million annual run rate in 12 months, which would be a 12-fold increase over the $0.8 million of revenues for FY 5/31/05. As a result, this should move Ingen into the black in FY 5/31/07 - for the first time. In turn, we would expect a favorable response from investors, moving IGTG's price up to an estimated $0.75 per share (even after an assumed 250% increase in shares). Thus, we think IGTG can approximately double in a year, providing it with a very attractive risk/return relationship. Continuing prospects of rapid growth should cause further appreciation thereafter, in our opinion'."
-------------------- Trust but verify!
IP: Logged |
posted
Based on the current pps you should be in the green now, unless you picked it up at the peak . I've sold off some and I will drop some more if this shoots up to the .5 range. My goal is to be sitting on some free shares and enjoy the ride.
-------------------- Trust but verify!
IP: Logged |
posted
IGTG is supposed to move to the OTCBB this month from the pr they had earlier. It has done a nice run up since last month when it was at .26 and now at .40. Still would not be a bad time to get into this at that price since I believe it will definatley run when it makes the move to the BB. [EMAIL]http://news.moneycentral.msn.com/ticker/article.asp?Feed=PR&Date=2060301&ID=5545431&Symbol=US:IGTG[/EMAIL]
New PR from this morning reccomended as an "Agressive Buy" from Empire Research.
-------------------- The thing I learned most about this is to take a profit when you can and you gotta have PATIENCE!
IP: Logged |
did you have shares b4 the RS? I have been in this for almost two years and the patience has paid off. I did buy alot more in early January and it is steadily moving on up. Go Go Go!!!
-------------------- The thing I learned most about this is to take a profit when you can and you gotta have PATIENCE!
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Frown]](frown.gif)
. I've sold off some and I will drop some more if this shoots up to the .5 range. My goal is to be sitting on some free shares and enjoy the ride.
